MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 14:49
MEI Pharma Total Liabilities (Quarterly): 2.872M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.872M |
June 30, 2024 | 8.355M |
March 31, 2024 | 20.23M |
December 31, 2023 | 19.05M |
September 30, 2023 | 19.89M |
June 30, 2023 | 96.18M |
March 31, 2023 | 99.83M |
December 31, 2022 | 99.22M |
September 30, 2022 | 126.28M |
June 30, 2022 | 125.43M |
March 31, 2022 | 126.62M |
December 31, 2021 | 132.21M |
September 30, 2021 | 144.52M |
June 30, 2021 | 124.63M |
March 31, 2021 | 141.16M |
December 31, 2020 | 130.38M |
September 30, 2020 | 131.68M |
June 30, 2020 | 132.67M |
March 31, 2020 | 22.12M |
December 31, 2019 | 29.82M |
September 30, 2019 | 21.64M |
June 30, 2019 | 34.73M |
March 31, 2019 | 48.04M |
December 31, 2018 | 42.84M |
September 30, 2018 | 54.99M |
Date | Value |
---|---|
June 30, 2018 | 54.20M |
March 31, 2018 | 4.484M |
December 31, 2017 | 5.209M |
September 30, 2017 | 4.465M |
June 30, 2017 | 4.866M |
March 31, 2017 | 4.989M |
December 31, 2016 | 3.32M |
September 30, 2016 | 18.71M |
June 30, 2016 | 5.512M |
March 31, 2016 | 4.025M |
December 31, 2015 | 3.378M |
September 30, 2015 | 3.127M |
June 30, 2015 | 4.959M |
March 31, 2015 | 6.638M |
December 31, 2014 | 6.882M |
September 30, 2014 | 5.308M |
June 30, 2014 | 4.616M |
March 31, 2014 | 3.518M |
December 31, 2013 | 2.428M |
September 30, 2013 | 1.465M |
June 30, 2013 | 1.675M |
March 31, 2013 | 1.782M |
December 31, 2012 | 1.797M |
September 30, 2012 | 1.63M |
June 30, 2012 | 1.774M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.872M
Minimum
Sep 2024
144.52M
Maximum
Sep 2021
86.66M
Average
112.23M
Median
Total Liabilities (Quarterly) Benchmarks
Avid Bioservices Inc | 276.01M |
Evoke Pharma Inc | 9.766M |
Revance Therapeutics Inc | 624.59M |
NovaBay Pharmaceuticals Inc | 2.805M |
Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 27.75M |
Shareholders Equity (Quarterly) | 24.88M |